Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer
Clinical trial NCT04791384 · TERMINATED
Trial details
- NCT number
- NCT04791384
- Sponsor
- Criterium, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-21
- Primary completion
- 2024-09-16
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.